Skip to main content

Table 1 Patients and tumors’ characteristics

From: High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers

 

Number of patients

(%)

 

204

100

Age

 Median, range

56

29–86

 <55 years

98

48.0

 ≥55 years

106

52.0

T

  

 T1

84

41.2

 T2

97

47.5

 T3

10

4.9

 T4

13

6.4

N

 N0

132

64.7

 N1

46

22.5

 N2

18

8.8

 N3

8

3.9

Histology

 Ductal

163

79.9

 Lobular

13

6.4

 Othera

28

13.7

SBR-EE grade

 1

9

4.5

 2

60

29.9

 3

132

65.7

 NE

3

 

Adjuvant chemotherapy

 No

60

29.7

 Yes

142

70.3

 Missing

2

 
  1. a6 invasive papillary carcinomas, 4 metaplastic carcinomas, 4 undifferentiated carcinomas, 3 apocrine carcinomas, 3 medullary carcinomas, 3 mixed ductal-lobular carcinomas, and one/each of the following histological subtypes: sarcomatoid carcinoma, adenoid cystic carcinoma, adenosquamous and neuroendocrine carcinoma
  2. NE not evaluated